Cargando…
Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark
BACKGROUND: Antipsychotic (AP) medication is increasingly used for many health conditions. Prenatal exposure to AP medication has been associated with several adverse outcomes, but the findings remain inconsistent. PURPOSE: We aimed to investigate prenatal exposure to AP medication and the use of pr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716673/ https://www.ncbi.nlm.nih.gov/pubmed/29238228 http://dx.doi.org/10.2147/CLEP.S145524 |
_version_ | 1783283997200089088 |
---|---|
author | Würtz, Anne Mette Lund Høstrup Vestergaard, Claus Rytter, Dorte Sørensen, Merete Juul Christensen, Jakob Vestergaard, Mogens Bech, Bodil Hammer |
author_facet | Würtz, Anne Mette Lund Høstrup Vestergaard, Claus Rytter, Dorte Sørensen, Merete Juul Christensen, Jakob Vestergaard, Mogens Bech, Bodil Hammer |
author_sort | Würtz, Anne Mette Lund |
collection | PubMed |
description | BACKGROUND: Antipsychotic (AP) medication is increasingly used for many health conditions. Prenatal exposure to AP medication has been associated with several adverse outcomes, but the findings remain inconsistent. PURPOSE: We aimed to investigate prenatal exposure to AP medication and the use of primary health care system in childhood. SUBJECTS AND METHODS: All live-born singletons in Denmark during 1997–2012 were identified in the nationwide Danish National Patient Register and followed until December 31, 2013 (n = 963,010). Information on prenatal exposure to AP medication was obtained from the Danish Register of Medicinal Product Statistics. Contacts to the general practitioner (GP) were used as a proxy for the overall health of the children. Negative binomial regression was used to calculate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for the association between prenatal exposure to AP medication and number and type of GP contacts, excluding routine well-child visits and vaccinations. The models were adjusted for sex and birth date of the child, maternal age, parity, cohabitation status, income, education, smoking status, diagnosis of substance abuse, severe psychiatric disorder, depression and epilepsy as well as the use of antiepileptic drugs, antidepressants, benzodiazepines and insulin. RESULTS: The prenatally AP-exposed children had 7% more GP contacts than unexposed children, IRR: 1.07 (95% CI: 1.03, 1.11). The association was slightly stronger among children of mothers with no diagnosis of severe psychiatric disorder (IRR: 1.08, 95% CI: 1.04–1.13) than among children of mothers with severe psychiatric disorder (IRR: 1.03, 95% CI: 0.96–1.11), but the difference was not statistically significant. We found no difference between prenatally AP-exposed children and their unexposed siblings, IRR: 1.00 (95% CI: 0.97–1.04) for total contacts. CONCLUSION: Children of women using AP medication in pregnancy had more GP contacts in childhood than children of mothers not using AP medication. However, this might be explained by confounding from maternal behavior and mental illness. |
format | Online Article Text |
id | pubmed-5716673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57166732017-12-13 Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark Würtz, Anne Mette Lund Høstrup Vestergaard, Claus Rytter, Dorte Sørensen, Merete Juul Christensen, Jakob Vestergaard, Mogens Bech, Bodil Hammer Clin Epidemiol Original Research BACKGROUND: Antipsychotic (AP) medication is increasingly used for many health conditions. Prenatal exposure to AP medication has been associated with several adverse outcomes, but the findings remain inconsistent. PURPOSE: We aimed to investigate prenatal exposure to AP medication and the use of primary health care system in childhood. SUBJECTS AND METHODS: All live-born singletons in Denmark during 1997–2012 were identified in the nationwide Danish National Patient Register and followed until December 31, 2013 (n = 963,010). Information on prenatal exposure to AP medication was obtained from the Danish Register of Medicinal Product Statistics. Contacts to the general practitioner (GP) were used as a proxy for the overall health of the children. Negative binomial regression was used to calculate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for the association between prenatal exposure to AP medication and number and type of GP contacts, excluding routine well-child visits and vaccinations. The models were adjusted for sex and birth date of the child, maternal age, parity, cohabitation status, income, education, smoking status, diagnosis of substance abuse, severe psychiatric disorder, depression and epilepsy as well as the use of antiepileptic drugs, antidepressants, benzodiazepines and insulin. RESULTS: The prenatally AP-exposed children had 7% more GP contacts than unexposed children, IRR: 1.07 (95% CI: 1.03, 1.11). The association was slightly stronger among children of mothers with no diagnosis of severe psychiatric disorder (IRR: 1.08, 95% CI: 1.04–1.13) than among children of mothers with severe psychiatric disorder (IRR: 1.03, 95% CI: 0.96–1.11), but the difference was not statistically significant. We found no difference between prenatally AP-exposed children and their unexposed siblings, IRR: 1.00 (95% CI: 0.97–1.04) for total contacts. CONCLUSION: Children of women using AP medication in pregnancy had more GP contacts in childhood than children of mothers not using AP medication. However, this might be explained by confounding from maternal behavior and mental illness. Dove Medical Press 2017-12-01 /pmc/articles/PMC5716673/ /pubmed/29238228 http://dx.doi.org/10.2147/CLEP.S145524 Text en © 2017 Würtz et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Würtz, Anne Mette Lund Høstrup Vestergaard, Claus Rytter, Dorte Sørensen, Merete Juul Christensen, Jakob Vestergaard, Mogens Bech, Bodil Hammer Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark |
title | Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark |
title_full | Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark |
title_fullStr | Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark |
title_full_unstemmed | Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark |
title_short | Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark |
title_sort | prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in denmark |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716673/ https://www.ncbi.nlm.nih.gov/pubmed/29238228 http://dx.doi.org/10.2147/CLEP.S145524 |
work_keys_str_mv | AT wurtzannemettelund prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark AT høstrupvestergaardclaus prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark AT rytterdorte prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark AT sørensenmeretejuul prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark AT christensenjakob prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark AT vestergaardmogens prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark AT bechbodilhammer prenatalexposuretoantipsychoticmedicationanduseofprimaryhealthcaresysteminchildhoodapopulationbasedcohortstudyindenmark |